Novavax, Inc. (NASDAQ:NVAX) Enrolls Pregnant Women In Second Phase Study Of RSV Vaccine

Boston, MA 10/15/2014 (wallstreetpr) – Novavax, Inc. (NASDAQ:NVAX) has initiated second phase clinical trial of its study concerning the evaluation of respiratory syncytial virus (RSV) vaccine on pregnant women. Aim Of The Study As briefed in the article, the biopharmaceutical company has started enrollment in the second phase of the RSV F-protein nanoparticle vaccine. Healthy women […]